ESHELMAN FREDRIC N
Insider CIK 1033409 · MDCO Executive Chairman, Director · LQDA 10% owner · FURX Director, 10% owner · ARAV Executive Chairman of Board, Director, 10% owner · GTHX Director, 10% owner · EYEN Director, 10% owner · LQDA 10% owner · VRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARAV Aravive, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 8,153,060 | — | $0 | 8,153,060 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 8,153,060 | — | $0 | 8,153,060 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2022-10-24 | 2022-10-26 | 16,306,120 | $0.92 | $15.00M | 25,517,889 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-09-23 | 2022-09-26 | 97,063 | — | $0 | 97,063 | SEC↗ |
| ARAV Aravive, Inc. | M Exercise deriv | 2022-04-01 | 2022-04-04 | 4,545,455 | — | $0 | 0 | SEC↗ |
| ARAV Aravive, Inc. | M Exercise | 2022-04-01 | 2022-04-04 | 4,545,455 | — | $0 | 9,211,769 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-03-29 | 2022-03-31 | 860,216 | $2.20 | $1.89M | 860,216 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2022-03-29 | 2022-03-31 | 860,216 | $2.33 | $2.00M | 4,666,314 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 4,545,455 | $2.20 | $10.00M | 4,545,455 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2021-11-17 | 2021-11-22 | 9,653 | — | $0 | 9,653 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2021-11-17 | 2021-11-22 | 6,963 | — | $0 | 1,299,750 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2021-09-10 | 2021-09-13 | 22,812 | — | $0 | 22,812 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2021-02-12 | 2021-02-17 | 2,875,000 | $7.29 | $20.96M | 3,806,098 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-26 | 2021-01-27 | 1,762,162 | $3.12 | $5.50M | 2,601,210 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-25 | 2021-01-26 | 719,287 | $2.97 | $2.14M | 4,363,372 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-22 | 2021-01-26 | 500,000 | $2.95 | $1.48M | 5,082,659 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-21 | 2021-01-22 | 328,250 | $2.96 | $971.6K | 5,582,659 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-20 | 2021-01-21 | 53,405 | $2.95 | $157.5K | 5,910,909 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-19 | 2021-01-21 | 93,835 | $2.97 | $278.7K | 5,964,314 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-15 | 2021-01-19 | 27,000 | $3.01 | $81.3K | 6,058,149 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-14 | 2021-01-15 | 34,466 | $3.02 | $104.1K | 6,085,149 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-13 | 2021-01-15 | 3,393 | $3.07 | $10.4K | 6,119,615 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-12 | 2021-01-13 | 99,335 | $3.06 | $304.0K | 6,123,008 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-11 | 2021-01-13 | 13,524 | $3.05 | $41.2K | 6,222,343 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-08 | 2021-01-11 | 71,902 | $3.08 | $221.5K | 6,235,867 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2021-01-07 | 2021-01-11 | 142,819 | $3.12 | $445.6K | 6,307,769 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-12-22 | 2020-12-28 | 7,949 | $3.14 | $25.0K | 6,450,588 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-12-21 | 2020-12-22 | 51,906 | $3.13 | $162.5K | 6,458,537 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-12-18 | 2020-12-22 | 53,309 | $3.14 | $167.4K | 6,510,443 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-12-14 | 2020-12-16 | 6,417 | $3.13 | $20.1K | 6,563,752 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-30 | 2020-12-01 | 200 | $3.13 | $626 | 6,570,169 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-27 | 2020-12-01 | 200 | $3.13 | $626 | 6,570,369 | SEC↗ |
| LQDA Liquidia Technologies Inc | S Sale | 2020-11-25 | 2020-11-27 | 17,364 | $3.13 | $54.3K | 6,570,569 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-25 | 2020-12-01 | 17,364 | $3.13 | $54.3K | 6,570,569 | SEC↗ |
| LQDA Liquidia Technologies Inc | S Sale | 2020-11-24 | 2020-11-25 | 283,465 | $3.15 | $892.9K | 6,587,933 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-24 | 2020-12-01 | 283,465 | $3.15 | $892.9K | 6,587,933 | SEC↗ |
| LQDA Liquidia Technologies Inc | S Sale | 2020-11-23 | 2020-11-24 | 133,346 | $3.16 | $421.4K | 6,871,398 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-23 | 2020-12-01 | 133,346 | $3.16 | $421.4K | 6,871,398 | SEC↗ |
| LQDA Liquidia Technologies Inc | D To issuer | 2020-11-19 | 2020-11-20 | 30,000 | $3.35 | $100.5K | 7,004,744 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2020-11-19 | 2020-12-01 | 30,000 | $3.35 | $100.5K | 7,004,744 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-09-14 | 2020-09-15 | 16,029 | — | $0 | 16,029 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2020-09-11 | 2020-09-15 | 9,820 | — | $0 | 9,820 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2020-09-11 | 2020-09-15 | 7,288 | — | $0 | 1,292,787 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-07-02 | 2020-07-02 | 1,875,000 | $8.00 | $15.00M | 7,034,744 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-06-01 | 2020-06-03 | 3,226 | — | $0 | 3,226 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-06-01 | 2020-06-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-04-06 | 2020-04-07 | 44,250 | $5.28 | $233.6K | 175,573 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-04-03 | 2020-04-07 | 35,000 | $4.85 | $169.8K | 131,323 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-04-02 | 2020-04-03 | 7,223 | $4.96 | $35.8K | 96,323 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-04-01 | 2020-04-03 | 45,000 | $4.89 | $220.1K | 89,100 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-03-31 | 2020-04-01 | 30,000 | $4.87 | $146.1K | 44,100 | SEC↗ |
| LQDA Liquidia Technologies Inc | P Buy | 2020-03-30 | 2020-04-01 | 14,100 | $4.76 | $67.1K | 14,100 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2019-08-16 | 2019-08-20 | 9,057 | — | $0 | 9,057 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2019-08-16 | 2019-08-20 | 8,038 | — | $0 | 1,285,499 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2018-07-24 | 2018-07-26 | 4,465 | — | $0 | 4,655 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2018-07-24 | 2018-07-26 | 4,033 | — | $0 | 1,277,461 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2018-05-31 | 2018-06-04 | 14,141 | — | $0 | 14,141 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2018-05-31 | 2018-06-04 | 3,766 | — | $0 | 1,132,149 | SEC↗ |
| EYEN EYENOVIA, INC. | P Buy | 2018-01-29 | 2018-02-06 | 335,000 | $10.00 | $3.35M | 1,273,428 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2017-12-08 | 2017-12-11 | 100,000 | $26.65 | $2.67M | 1,128,383 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2017-12-07 | 2017-12-11 | 100,000 | $26.46 | $2.65M | 1,028,383 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-11-13 | 2017-11-15 | 250,000 | $19.73 | $4.93M | 250,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2017-07-11 | 2017-07-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2017-05-25 | 2017-05-30 | 13,577 | — | $0 | 13,577 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2017-05-25 | 2017-05-30 | 3,237 | — | $0 | 928,383 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 6,893,224 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 2,524,233 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 3,139,151 | — | $0 | 3,139,151 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-22 | 2017-05-24 | 300,000 | $15.00 | $4.50M | 3,439,151 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2017-05-05 | 2017-05-05 | 25,406 | — | $0 | 38,298 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2017-05-03 | 2017-05-05 | 4,904 | $9.66 | $47.4K | 12,892 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-12-08 | 2016-12-08 | 19,188 | $32.51 | $623.8K | 919,645 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-12-08 | 2016-12-08 | 5,501 | $33.19 | $182.6K | 925,146 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-12-07 | 2016-12-08 | 86,587 | $32.90 | $2.85M | 900,457 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-12-07 | 2016-12-08 | 172,764 | $33.61 | $5.81M | 813,870 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-12-06 | 2016-12-08 | 337,680 | $34.15 | $11.53M | 641,106 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2016-07-01 | 2016-07-06 | 26 | $23.78 | $618 | 17,796 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-06-17 | 2016-06-21 | 16,726 | — | $0 | 17,822 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2016-05-26 | 2016-05-31 | 14,700 | — | $0 | 14,700 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award | 2016-05-26 | 2016-05-31 | 3,426 | — | $0 | 303,426 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy | 2016-05-12 | 2016-05-13 | 300,000 | $33.68 | $10.10M | 300,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-03-11 | 2016-03-15 | 1,096 | — | $0 | 1,096 | SEC↗ |
| MDCO MEDICINES CO /DE | P Buy deriv | 2015-11-23 | 2015-11-25 | 1,000 | $538.90 | $538.9K | 1,000 | SEC↗ |
| MDCO MEDICINES CO /DE | A Award deriv | 2015-08-28 | 2015-09-01 | 24,080 | — | $0 | 24,080 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 65,876 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 98,813 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 132,689 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 2,673,522 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 140 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 41,666 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2013-06-30 | 2013-07-02 | 7,161 | — | $0 | 2,673,522 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2012-06-21 | 2012-06-22 | 65,875 | — | $0 | 65,876 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2012-06-21 | 2012-06-22 | 65,875 | $9.11 | $600.1K | 132,689 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-06-14 | 2012-06-15 | 34,133 | $19.04 | $649.9K | 2,666,361 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-06-13 | 2012-06-15 | 44,193 | $18.33 | $810.1K | 2,632,228 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-06-01 | 2012-06-04 | 50,319 | $19.72 | $992.3K | 2,588,035 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-31 | 2012-06-04 | 70,075 | $20.06 | $1.41M | 2,537,716 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-30 | 2012-05-31 | 96,321 | $19.87 | $1.91M | 2,467,641 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-29 | 2012-05-31 | 72,431 | $19.96 | $1.45M | 2,371,320 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-25 | 2012-05-29 | 1,454 | $18.45 | $26.8K | 2,298,889 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-24 | 2012-05-25 | 27,000 | $17.99 | $485.7K | 2,297,435 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-23 | 2012-05-24 | 20,000 | $17.73 | $354.6K | 2,270,435 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-22 | 2012-05-24 | 35,000 | $16.93 | $592.5K | 2,250,435 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-21 | 2012-05-22 | 2,400 | $16.15 | $38.8K | 2,215,435 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-18 | 2012-05-21 | 25,000 | $15.28 | $382.0K | 2,213,035 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-15 | 2012-03-19 | 7,102 | $23.91 | $169.8K | 2,188,035 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-14 | 2012-03-15 | 22,713 | $23.75 | $539.4K | 2,180,933 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-13 | 2012-03-15 | 22,594 | $23.45 | $529.8K | 2,158,220 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-12 | 2012-03-12 | 22,351 | $22.69 | $507.1K | 2,060,626 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-09 | 2012-03-12 | 15,237 | $22.59 | $344.2K | 2,038,275 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-08 | 2012-03-12 | 14,914 | $22.52 | $335.9K | 2,023,038 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-07 | 2012-03-15 | 75,000 | $21.75 | $1.63M | 2,135,626 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-06 | 2012-03-07 | 15,237 | $20.87 | $318.0K | 2,008,124 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-03-05 | 2012-03-07 | 15,237 | $20.55 | $313.1K | 1,992,887 | SEC↗ |